Virtu Financial’s Entero Therapeutics ENTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,730
| Closed | -$11K | – | 2176 |
|
|
2024
Q3 | $11K | Buy |
+10,730
| New | +$11K | ﹤0.01% | 1194 |
|
|
2023
Q4 | – | Sell |
-850
| Closed | -$15K | – | 2089 |
|
|
2023
Q3 | $15K | Buy |
+850
| New | +$15K | ﹤0.01% | 1060 |
|
|
2022
Q4 | – | Sell |
-30
| Closed | -$19K | – | 2229 |
|
|
2022
Q3 | $19K | Buy |
30
+28
| +1,400% | +$17.7K | ﹤0.01% | 1411 |
|
|
2022
Q2 | $4K | Buy |
+2
| New | +$4K | ﹤0.01% | 1475 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | -$74K | – | 2043 |
|
|
2021
Q2 | $74K | Hold |
1
| – | – | 0.01% | 1268 |
|
|
2021
Q1 | $104K | Buy |
+1
| New | +$104K | 0.01% | 1313 |
|
|
2019
Q4 | – | Sell |
-1
| Closed | -$51K | – | 1211 |
|
|
2019
Q3 | $51K | Buy |
+1
| New | +$51K | ﹤0.01% | 1192 |
|
|
2019
Q1 | – | Hold |
0
| – | -$12K | – | 1913 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1418 |
|